 |
The 2ml Cross-linked Lip Filler represents a versatile solution in aesthetic medicine, offering practitioners increased dosage flexibility for comprehensive lip enhancement procedures. This larger-volume formulation caters to patients requiring more significant volumization or those seeking to address both lip augmentation and perioral wrinkles in a single session. The product builds on the proven efficacy of crosslinked hyaluronic acid, delivering sustained results with a natural feel and appearance.
HA Content | Particle Size | Needle | Duration | Model No. | |
| 20mg/ml 24mg/ml | 0.15-0.18mm | 2*27G | 6-12months | 1ml, 2ml |
Test Result | ||
Test Items | Standard Provision | Result |
Appearance | Colorless, transparent | Colorless, transparent |
Effective Range | ≥Standard 90% | 95 |
Hyaluronate Content | Standard Count90.0%-120.0(m/m) | 99.7 |
Transmittance | ≥85.0%（m/m） | 93.5 |
PH | 6.8-7.5 | 6.85 |
Osmotic Pressure | 270-350mOsmol/L | 292 |
Cross-linking Agent Residue | ≤2μg/g | COMPLIED |
Protein Content | ≤0.15 %(m/m) | 0.03 |
UV Absorbance | A280nm≤1.0 | 0.03 |
A260nm≤1.5 | 0.06 | |
Protein Content | ≤10ug/g | <10 |
Bacteria Test | Should have no bacterial | COMPLIED |
Bacteria Endotoxin Test | <0.5Eu/mg | COMPLIED |
Designed for professional use, this filler combines high viscosity with optimal flow properties, allowing for precise placement even in delicate lip areas. Its 2ml syringe format reduces the need for multiple syringe changes during treatment, streamlining the procedure and enhancing patient comfort. Clinical data supports that this formulation maintains effective volumization for 6–9 months in most patients, with extended results observed in individuals with slower metabolic rates.
The 2ml syringe provides sufficient product for comprehensive lip reshaping, including full lip volumization, border definition, and correction of vertical lip lines. This eliminates the need for combining multiple smaller syringes, reducing procedural time and potential contamination risks.
Featuring a higher crosslinking ratio (8% BDDE) compared to standard fillers, this product offers superior lifting capacity and resistance to degradation. This enhanced structural integrity makes it particularly effective for patients with thin lip tissue or those seeking more dramatic yet natural-looking results.
The proprietary gel matrix balances firmness and plasticity, allowing for smooth injection through fine needles while maintaining shape retention post-treatment. This consistency enables practitioners to sculpt precise lip contours that withstand normal facial movements.
Each syringe contains 0.3% lidocaine evenly distributed throughout the gel, ensuring continuous pain management during injection. This eliminates the need for separate local anesthetic injections, reducing procedural steps and patient discomfort.
For full lip augmentation, the recommended initial dosage ranges from 1.0–1.5ml per treatment session, with the remaining product reserved for precise sculpting and correction of asymmetries. Practitioners should assess lip anatomy and patient goals to determine optimal dosage distribution between upper and lower lips.
The filler is administered using a 25–27G needle, with preferred techniques including linear threading for volumization and fanning for border definition. The deep dermal plane is targeted for volume enhancement, while superficial placement is used for fine lines and definition.
Practitioners are advised to employ a layered injection approach, starting with foundational volume in the deeper dermis, followed by superficial layers for contour refinement. This technique minimizes the risk of lump formation and ensures uniform product distribution.
Patients should be monitored for 15–20 minutes post-injection for immediate adverse reactions. Recommended aftercare includes avoiding pressure on the treated area, refraining from makeup application for 24 hours, and using cold compresses as needed to manage swelling.
The 2ml filler can be used for first-time patients, though practitioners typically administer 0.5–1ml initially, with remaining product stored appropriately for follow-up treatments within 4 weeks if needed.
Beyond the volume difference, the 2ml formulation features slightly higher crosslinking density to support larger volume applications, providing enhanced longevity and structural support in areas requiring more significant augmentation.
While optimized for lip enhancement, this filler is also suitable for treating perioral rhytids (lip lines) and marionette lines, making it a versatile option for lower facial rejuvenation.
Unused portions can be stored at 2–25°C for up to 24 hours after initial opening, provided proper aseptic techniques are maintained. However, most practitioners recommend single-patient use per session.
Patients with faster metabolisms may experience results lasting 6–7 months, while those with slower metabolisms often enjoy results for 8–9 months. Factors like smoking and sun exposure can accelerate degradation.
HA Content | Particle Size | Needle | Duration | Model No. | |
| 20mg/ml 24mg/ml | 0.15-0.18mm | 2*27G | 6-12months | 1ml, 2ml |
Test Result | ||
Test Items | Standard Provision | Result |
Appearance | Colorless, transparent | Colorless, transparent |
Effective Range | ≥Standard 90% | 95 |
Hyaluronate Content | Standard Count90.0%-120.0(m/m) | 99.7 |
Transmittance | ≥85.0%（m/m） | 93.5 |
PH | 6.8-7.5 | 6.85 |
Osmotic Pressure | 270-350mOsmol/L | 292 |
Cross-linking Agent Residue | ≤2μg/g | COMPLIED |
Protein Content | ≤0.15 %(m/m) | 0.03 |
UV Absorbance | A280nm≤1.0 | 0.03 |
A260nm≤1.5 | 0.06 | |
Protein Content | ≤10ug/g | <10 |
Bacteria Test | Should have no bacterial | COMPLIED |
Bacteria Endotoxin Test | <0.5Eu/mg | COMPLIED |
Designed for professional use, this filler combines high viscosity with optimal flow properties, allowing for precise placement even in delicate lip areas. Its 2ml syringe format reduces the need for multiple syringe changes during treatment, streamlining the procedure and enhancing patient comfort. Clinical data supports that this formulation maintains effective volumization for 6–9 months in most patients, with extended results observed in individuals with slower metabolic rates.
The 2ml syringe provides sufficient product for comprehensive lip reshaping, including full lip volumization, border definition, and correction of vertical lip lines. This eliminates the need for combining multiple smaller syringes, reducing procedural time and potential contamination risks.
Featuring a higher crosslinking ratio (8% BDDE) compared to standard fillers, this product offers superior lifting capacity and resistance to degradation. This enhanced structural integrity makes it particularly effective for patients with thin lip tissue or those seeking more dramatic yet natural-looking results.
The proprietary gel matrix balances firmness and plasticity, allowing for smooth injection through fine needles while maintaining shape retention post-treatment. This consistency enables practitioners to sculpt precise lip contours that withstand normal facial movements.
Each syringe contains 0.3% lidocaine evenly distributed throughout the gel, ensuring continuous pain management during injection. This eliminates the need for separate local anesthetic injections, reducing procedural steps and patient discomfort.
For full lip augmentation, the recommended initial dosage ranges from 1.0–1.5ml per treatment session, with the remaining product reserved for precise sculpting and correction of asymmetries. Practitioners should assess lip anatomy and patient goals to determine optimal dosage distribution between upper and lower lips.
The filler is administered using a 25–27G needle, with preferred techniques including linear threading for volumization and fanning for border definition. The deep dermal plane is targeted for volume enhancement, while superficial placement is used for fine lines and definition.
Practitioners are advised to employ a layered injection approach, starting with foundational volume in the deeper dermis, followed by superficial layers for contour refinement. This technique minimizes the risk of lump formation and ensures uniform product distribution.
Patients should be monitored for 15–20 minutes post-injection for immediate adverse reactions. Recommended aftercare includes avoiding pressure on the treated area, refraining from makeup application for 24 hours, and using cold compresses as needed to manage swelling.
The 2ml filler can be used for first-time patients, though practitioners typically administer 0.5–1ml initially, with remaining product stored appropriately for follow-up treatments within 4 weeks if needed.
Beyond the volume difference, the 2ml formulation features slightly higher crosslinking density to support larger volume applications, providing enhanced longevity and structural support in areas requiring more significant augmentation.
While optimized for lip enhancement, this filler is also suitable for treating perioral rhytids (lip lines) and marionette lines, making it a versatile option for lower facial rejuvenation.
Unused portions can be stored at 2–25°C for up to 24 hours after initial opening, provided proper aseptic techniques are maintained. However, most practitioners recommend single-patient use per session.
Patients with faster metabolisms may experience results lasting 6–7 months, while those with slower metabolisms often enjoy results for 8–9 months. Factors like smoking and sun exposure can accelerate degradation.
